Starling Oncology, Inc. (DFPH) Operating margin 2020–2025
Starling Oncology, Inc. (DFPH) operating margin by fiscal year — reported operating income divided by reported revenue.
-7.2%FY2025 · since FY2020: -4.4% → -7.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7.2% | +8.1 pp |
| FY2024 | -15.3% | +8.5 pp |
| FY2023 | -23.8% | +8.7 pp |
| FY2022 | -32.5% | -9.9 pp |
| FY2021 | -22.6% | -18.2 pp |
| FY2020 | -4.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More DFPH financial trends
DFPH RevenueDFPH Net incomeDFPH Net marginDFPH Gross profitDFPH Gross marginDFPH Operating incomeDFPH Operating cash flowDFPH Free cash flowDFPH Capital expendituresDFPH Return on equityDFPH Stock buybacksDFPH Dividends paidDFPH Total assetsDFPH Total liabilitiesDFPH Shareholders’ equityDFPH overview →